Multiple Sclerosis

Computer generated image of a neuron.

2011 to 2017 Saw Increase in Spending on DMTs for MS

From 2011 to 2017, there was an increase in gross annual expenditures on multiple sclerosis (MS) disease-modifying therapies (DMTs), with increased spending mainly driven by increases in per-prescription costs.

MENACTRIMS Guidelines for Multiple Sclerosis Updated

In a revised 2019 guideline, updated recommendations from the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) are presented for the diagnosis and treatment of multiple sclerosis (MS).

AAN Issues Guideline Update for Immunization in Patients With MS

AAN has issued a practice guideline update for vaccine-preventable infections and immunizations for individuals with multiple sclerosis (MS). A subcommittee of the AAN — tasked with developing, disseminating and implementing these guidelines — found improvements and additions to the recommendations previously issued in 2002.

Next post in Medicine